BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/7/2023 1:29:18 AM | Browse: 384 | Download: 1202
 |
Received |
|
2023-06-04 13:25 |
|
Peer-Review Started |
|
2023-06-04 13:27 |
|
First Decision by Editorial Office Director |
|
2023-07-28 08:48 |
|
Return for Revision |
|
2023-07-28 08:48 |
|
Revised |
|
2023-08-18 15:52 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-09-05 02:51 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-09-05 07:35 |
|
Articles in Press |
|
2023-09-05 07:35 |
|
Edit the Manuscript by Language Editor |
|
2023-08-31 10:26 |
|
Typeset the Manuscript |
|
2023-09-05 08:48 |
|
Publish the Manuscript Online |
|
2023-09-07 01:29 |
| ISSN |
2644-3236 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Drug-induced liver injury and COVID-19: Use of artificial intelligence and the updated Roussel Uclaf Causality Assessment Method in clinical practice
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Gabriela Xavier Ortiz, Ana Helena Dias Pereira dos Santos Ulbrich, Gabriele Lenhart, Henrique Dias Pereira dos Santos, Karin Hepp Schwambach, Matheus William Becker and Carine Raquel Blatt |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gabriela Xavier Ortiz, MSc, Academic Research, Graduate Program in Medicine – Hepatology, Federal University of Health Sciences of Porto Alegre, Sarmento Leite, 245, Porto Alegre 90050-170, Brazil. gabrielax@ufcspa.edu.br |
| Key Words |
Chemical and drug induced liver injury; RUCAM; Artificial intelligence; COVID-19; Liver injury |
| Core Tip |
This is a real-life study that correlated hospital clinical pharmacy data with artificial intelligence (AI) and pharmacovigilance in coronavirus disease 2019 (COVID-19) inpatients. Inpatient screening for liver injury was made with AI and drug-induced liver injury was evaluated with the Roussel Uclaf Causality Assessment Method (RUCAM) algorithm. A total of 17 COVID-19 inpatients were evaluated, there were 31 suspected drugs, RUCAM score: possible (n = 24), probable (n = 5), and unlikely (n = 2). This study contributed to the patient safety and pharmacovigilance database. These results are included in a project of clinical pharmacy using AI tools. |
| Publish Date |
2023-09-07 01:29 |
| Citation |
Ortiz GX, Ulbrich AHDPS, Lenhart G, dos Santos HDP, Schwambach KH, Becker MW, Blatt CR. Drug-induced liver injury and COVID-19: Use of artificial intelligence and the updated Roussel Uclaf Causality Assessment Method in clinical practice. Artif Intell Gastroenterol 2023; 4(2): 36-47 |
| URL |
https://www.wjgnet.com/2644-3236/full/v4/i2/36.htm |
| DOI |
https://dx.doi.org/10.35712/aig.v4.i2.36 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
